AU Patent

AU2018346358A1 — Stable solutions of multicyclic antidepressants

Assigned to Leyden Technologies BV · Expires 2020-04-09 · 6y expired

What this patent protects

The invention relates to the field of medicine, specifically the field of atypical antipsychotics. New compositions are provided that provide drug solutions of high stability.

USPTO Abstract

The invention relates to the field of medicine, specifically the field of atypical antipsychotics. New compositions are provided that provide drug solutions of high stability.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018346358A1
Jurisdiction
AU
Classification
—
Expires
2020-04-09
Drug substance claim
No
Drug product claim
No
Assignee
Leyden Technologies BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.